|Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …|
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
|Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention …|
EL Korenromp, RG White, KK Orroth, R Bakker, A Kamali, D Serwadda, ...
The Journal of infectious diseases 191 (Supplement_1), S168-S178, 2005
|HIV and aging--preparing for the challenges ahead|
MD Till Bärnighausen, JN MIA
The New England journal of medicine 366 (14), 1270, 2012
|The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa|
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
AIDS (London, England) 26 (0 1), 2012
|Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study|
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS Med 10 (10), e1001534, 2013
|Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan …|
EE Freeman, KK Orroth, RG White, JR Glynn, R Bakker, MC Boily, ...
Sexually transmitted infections 83 (suppl 1), i17-i24, 2007
|Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?|
RG White, JR Glynn, KK Orroth, EE Freeman, R Bakker, HA Weiss, ...
Aids 22 (14), 1841-1850, 2008
|Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study|
RG White, KK Orroth, EL Korenromp, R Bakker, M Wambura, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (4), 1500-1513, 2004
|Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study|
KK Orroth, EE Freeman, R Bakker, A Buvé, JR Glynn, MC Boily, RG White, ...
Sexually transmitted infections 83 (suppl 1), i5-i16, 2007
|Ageing with HIV in south africa|
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
AIDS (London, England) 25 (13), 2011
|Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?|
RG White, KK Orroth, JR Glynn, EE Freeman, R Bakker, JDF Habbema, ...
Journal of acquired immune deficiency syndromes (1999) 47 (3), 346, 2008
|HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial|
EL Korenromp, R Bakker, SJ Vlas, RH Gray, MJ Wawer, D Serwadda, ...
Aids 16 (16), 2209-2218, 2002
|The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa|
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
|Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment|
LE Coffeng, WA Stolk, A Hoerauf, D Habbema, R Bakker, AD Hopkins, ...
PloS one 9 (12), e115886, 2014
|cAMP-mediated effects of ouabain and theophylline on paracellular ion selectivity|
R Bakker, JA Groot
American Journal of Physiology-Gastrointestinal and Liver Physiology 246 (2 …, 1984
|Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually …|
KK Orroth, RG White, EL Korenromp, R Bakker, J Changalucha, ...
Sexually transmitted diseases 33 (9), 536-544, 2006
|Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa|
EE Freeman, RG White, R Bakker, KK Orroth, HA Weiss, A Buvé, ...
Vaccine 27 (6), 940-946, 2009
|Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?|
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
|HIV spread and partnership reduction for different patterns of sexual behaviour‐a study with the microsimulation model STDSIM|
EL Korenromp, C Van Vliet, R Bakker, SJ de Vlas, JDF Habbema
Mathematical Population Studies 8 (2), 135-173, 2000
|The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model|
JAC Hontelez, N Nagelkerke, T Bärnighausen, R Bakker, F Tanser, ...
Vaccine 29 (36), 6100-6106, 2011